ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
3,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3,3,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
3,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
5,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
8,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
9,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
9,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
11,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
12,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
13,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
14,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
15,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
16,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
16,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
17,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
18,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
19,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
19,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
19,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
20,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
21,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
21,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
22,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
22,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
22,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
23,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
24,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
24,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
25,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
26,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
27,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
27,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
28,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
29,1,Arterial occlusive disease,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
30,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
31,1,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
32,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
32,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
33,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
33,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
34,1,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
35,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
36,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
37,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
37,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
37,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
37,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
38,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
39,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
39,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
40,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
40,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
41,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
42,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
42,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
43,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
43,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
43,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
44,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
44,2,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
44,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
44,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
44,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
45,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
45,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
46,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
46,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
47,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
47,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
47,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
48,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
49,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
49,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
49,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
49,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
49,5,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
49,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
50,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
50,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
50,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
51,2,Headache,Headaches NEC,Headaches,Nerv,N
51,3,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
51,4,Pituitary apoplexy,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
51,5,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
51,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
52,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
52,3,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
53,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
53,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
54,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
54,2,Vein discolouration,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
55,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
56,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
56,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
57,1,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
58,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
58,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
59,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
60,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
61,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
61,2,Anal skin tags,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
61,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
61,4,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
62,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
62,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
63,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
63,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
63,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
63,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
64,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
64,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
64,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
64,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
65,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
66,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
66,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
67,1,Teratoma,Germ cell neoplasms site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
68,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
68,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
68,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
68,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
68,5,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
68,6,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
69,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
70,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
71,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
72,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
72,2,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
72,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
73,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
73,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
74,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
74,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
74,3,Apoptosis,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
74,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
74,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
74,6,Reticulocytopenia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
74,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
75,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
76,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
76,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
76,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
77,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
77,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
78,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
78,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
79,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
79,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
80,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
81,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
81,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
82,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
82,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
83,1,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
84,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
84,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
85,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
86,1,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
87,1,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
88,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
89,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
90,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
90,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
90,3,Migraine,Migraine headaches,Headaches,Nerv,N
90,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
91,1,Paralysis recurrent laryngeal nerve,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
92,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,2,Paralysis recurrent laryngeal nerve,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
93,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
93,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
93,5,Paralysis recurrent laryngeal nerve,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
94,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,2,Paralysis recurrent laryngeal nerve,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
95,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
95,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
96,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
97,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
98,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
99,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
100,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
101,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
101,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
101,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
101,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
102,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
103,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
103,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
103,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
105,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
105,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
106,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
106,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
107,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
107,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
108,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
108,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
109,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
109,2,Renal abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
110,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
110,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,3,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
110,4,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
110,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
111,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
111,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
111,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
111,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
111,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
111,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
111,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
111,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
112,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
112,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
112,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
113,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
113,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,3,Langerhans' cell histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
113,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
113,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
113,6,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
114,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
115,1,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
116,1,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
117,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
117,2,Soft tissue sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
117,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
119,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,2,Hodgkin's disease lymphocyte predominance type refractory,Hodgkin's disease lymphocyte predominance type,Lymphomas Hodgkin's disease,Neopl,N
120,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,2,Hodgkin's disease lymphocyte predominance type refractory,Hodgkin's disease lymphocyte predominance type,Lymphomas Hodgkin's disease,Neopl,N
121,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
121,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
123,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
123,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
123,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
123,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
124,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
124,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
124,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
125,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
126,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
126,2,Optic glioma,Ocular neoplasms malignancy unspecified,Ocular neoplasms,Neopl,N
127,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
128,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
128,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
128,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
128,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
128,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
128,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
129,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
130,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
131,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
132,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
133,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
133,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
133,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
133,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
134,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
135,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
135,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
135,3,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
135,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
136,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
136,2,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
136,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
137,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
137,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
137,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
137,4,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
137,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
138,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
138,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
138,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
138,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
139,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
139,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
139,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
139,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
139,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
139,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
139,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
140,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
140,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
141,1,Foetal anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
141,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
141,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
142,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
143,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
144,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
144,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
144,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
145,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
145,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
146,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
146,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
146,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
147,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
147,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
147,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
147,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
148,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
148,3,Langerhans' cell histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
148,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
149,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
150,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
150,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
151,1,Vagus nerve paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
152,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
152,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
152,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
152,4,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
152,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
153,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
153,2,Non-Hodgkin's lymphoma stage IV,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
154,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
154,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
155,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
155,3,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
156,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
156,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
156,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
156,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
156,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
156,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
157,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
157,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
158,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
159,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
160,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
161,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
161,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
161,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
162,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
162,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
162,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
163,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
163,2,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
163,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
164,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
165,1,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
165,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
166,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
167,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
167,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
167,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
167,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
167,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
167,6,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
167,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
168,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
168,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
169,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
169,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
169,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
171,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
171,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
171,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
171,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
172,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
173,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
173,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
174,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
174,2,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
174,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
174,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
174,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
174,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
174,7,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
174,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
174,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
